In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K.
A systematic evaluation of the susceptibility of all Chlamydia trachomatis urogenital serovars (D through K) to levofloxacin, erythromycin, doxycycline, clarithromycin, and azithromycin was performed. All C. trachomatis serovars had comparable susceptibilities with respect to the various antimicrobials tested, thus confirming the homogeneous data so far obtained regarding the susceptibility of C. trachomatis to antimicrobial agents.
Donati
Manuela
M
Section of Microbiology DESOS, Policlinico S. Orsola, University of Bologna, Via Massarenti 9, Bologna 40138, Italy. manuela.donati@unibo.it
Di Francesco
Antonietta
A
D'Antuono
Antonietta
A
Delucca
Federica
F
Shurdhi
Alisa
A
Moroni
Alessandra
A
Baldelli
Raffaella
R
Cevenini
Roberto
R
D000890:Anti-Infective Agents / Q000494:pharmacology*; D017963:Azithromycin / Q000494:pharmacology; D002692:Chlamydia trachomatis / Q000187:drug effects* / Q000235:genetics; D017291:Clarithromycin / Q000494:pharmacology; D004318:Doxycycline / Q000494:pharmacology; D004917:Erythromycin / Q000494:pharmacology; D005838:Genotype; D064704:Levofloxacin; D008826:Microbial Sensitivity Tests; D015242:Ofloxacin / Q000494:pharmacology
D000890:Anti-Infective Agents; D004917:Erythromycin; D064704:Levofloxacin; D017963:Azithromycin; D015242:Ofloxacin; D017291:Clarithromycin; D004318:Doxycycline